HER2 is short for human epidermal growth factor receptor 2. Researchers discovered HER2 breast cancer in the 1980s. Too many copies of the HER2 gene or its overexpression appeared to cause an ...

South Korea’s Celltrion has started work on a biosimilar version of pembrolizumab ... launch in Europe is a version of Roche’s Herceptin (trastuzumab). Biosimilar companies are poised to ...